Wiman B, Lindahl T, Almqvist A
Department of Clinical Chemistry, Karolinska Hospital, Stockholm, Sweden.
Thromb Haemost. 1988 Jun 16;59(3):392-5.
Gel-filtration experiments of mixtures of functionally active and inactive forms of plasminogen activator inhibitor (PAI) with human plasma or bovine serum albumin have provided evidence for the existence of a discrete binding protein of PAI in plasma. Most likely it is a glycoprotein with a molecular weight of approximately 150,000. The data suggest that it forms a very stable complex with functionally active forms of PAI, but not with the inactive or "latent" PAI. However, the PAI activity seems not to be significantly altered by the interaction with the binding protein. Assuming that a stoichiometric complex is formed, titration experiments suggest that a pool of normal human plasma contains about 40-50 mg of PAI-binding protein liter.
对纤溶酶原激活物抑制剂(PAI)功能活性形式与非活性形式的混合物,分别与人血浆或牛血清白蛋白进行凝胶过滤实验,结果表明血浆中存在一种PAI离散结合蛋白。它很可能是一种分子量约为150,000的糖蛋白。数据显示,它与PAI的功能活性形式形成非常稳定的复合物,但不与非活性或“潜在”PAI形成复合物。然而,PAI活性似乎不会因与结合蛋白相互作用而发生显著改变。假设形成了化学计量复合物,滴定实验表明,正常人血浆中每升约含有40 - 50毫克PAI结合蛋白。